Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Chronic Heart Failure

  Free Subscription


Articles published in Am Heart J

Retrieve available abstracts of 105 articles:
HTML format
Text format



Single Articles


    April 2018
  1. VELAZQUEZ EJ, Morrow DA, DeVore AD, Ambrosy AP, et al
    Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial.
    Am Heart J. 2018;198:145-151.
    PubMed     Text format     Abstract available


  2. KHAZANIE P, Hellkamp AS, Fonarow GC, Curtis LH, et al
    Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry.
    Am Heart J. 2018;198:123-128.
    PubMed     Text format     Abstract available


    March 2018
  3. SULLIVAN LT 2ND, Randolph T, Merrill P, Jackson LR 2nd, et al
    Representation of black patients in randomized clinical trials of heart failure with reduced ejection fraction.
    Am Heart J. 2018;197:43-52.
    PubMed     Text format     Abstract available


    February 2018
  4. VAN BOVEN N, Battes LC, Akkerhuis KM, Rizopoulos D, et al
    Toward personalized risk assessment in patients with chronic heart failure: Detailed temporal patterns of NT-proBNP, troponin T, and CRP in the Bio-SHiFT study.
    Am Heart J. 2018;196:36-48.
    PubMed     Text format    


    January 2018
  5. MANGLA A, Doukky R, Richardson D, Avery EF, et al
    Design of a bilevel clinical trial targeting adherence in heart failure patients and their providers: The Congestive Heart Failure Adherence Redesign Trial (CHART).
    Am Heart J. 2018;195:139-150.
    PubMed     Text format     Abstract available


    December 2017
  6. DA ROSA PR, Rohde LE, Doebber M, Ribeiro ALP, et al
    Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: The ReBIC-1 trial.
    Am Heart J. 2017;194:125-131.
    PubMed     Text format     Abstract available


    November 2017
  7. SHADDY R, Canter C, Halnon N, Kochilas L, et al
    Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study).
    Am Heart J. 2017;193:23-34.
    PubMed     Text format     Abstract available


    October 2017
  8. CERBIN LP, Ambrosy AP, Mentz RJ
    Building the case for aerobic exercise in ambulatory patients with heart failure and a reduced ejection fraction.
    Am Heart J. 2017;192:e3.
    PubMed     Text format    


  9. TAYLOR R, Dalal H, Davies R, Doherty P, et al
    Cardiac rehabilitation in heart failure with reduced ejection fraction: A "should take it and not leave it" intervention.
    Am Heart J. 2017;192:e1-e2.
    PubMed     Text format    


  10. GAGGIN HK, Chen-Tournoux AA, Christenson RH, Doros G, et al
    Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
    Am Heart J. 2017;192:26-37.
    PubMed     Text format     Abstract available


  11. ADIR Y, Guazzi M, Offer A, Temporelli PL, et al
    Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.
    Am Heart J. 2017;192:120-127.
    PubMed     Text format     Abstract available


    September 2017
  12. SHERWOOD A, Hill LK, Blumenthal JA, Adams KF Jr, et al
    Blood pressure reactivity to psychological stress is associated with clinical outcomes in patients with heart failure.
    Am Heart J. 2017;191:82-90.
    PubMed     Text format     Abstract available


  13. LUO N, Teng TK, Tay WT, Anand IS, et al
    Multinational and multiethnic variations in health-related quality of life in patients with chronic heart failure.
    Am Heart J. 2017;191:75-81.
    PubMed     Text format     Abstract available


  14. FRIEDMAN DJ, Al-Khatib SM, Zeitler EP, Han J, et al
    New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials.
    Am Heart J. 2017;191:21-29.
    PubMed     Text format     Abstract available


    August 2017
  15. AUSTIN CO, Landolfo K, Parikh PP, Patel PC, et al
    Retained cardiac implantable electronic device fragments are not associated with magnetic resonance imaging safety issues, morbidity, or mortality after orthotopic heart transplant.
    Am Heart J. 2017;190:46-53.
    PubMed     Text format     Abstract available


  16. GIMPELEWICZ C, Metra M, Cleland JGF, Szecsody P, et al
    Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial.
    Am Heart J. 2017;190:113-122.
    PubMed     Text format     Abstract available


    July 2017
  17. RANDOLPH TC, Hellkamp AS, Zeitler EP, Fonarow GC, et al
    Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes.
    Am Heart J. 2017;189:48-58.
    PubMed     Text format     Abstract available


  18. HARIKRISHNAN S, Sanjay G, Agarwal A, Kumar NP, et al
    One-year mortality outcomes and hospital readmissions of patients admitted with acute heart failure: Data from the Trivandrum Heart Failure Registry in Kerala, India.
    Am Heart J. 2017;189:193-199.
    PubMed     Text format     Abstract available


  19. DEVORE AD, Thomas L, Albert NM, Butler J, et al
    Change the management of patients with heart failure: Rationale and design of the CHAMP-HF registry.
    Am Heart J. 2017;189:177-183.
    PubMed     Text format     Abstract available


  20. CUNNINGHAM JW, Nathan AS, Rhodes J, Shafer K, et al
    Decline in peak oxygen consumption over time predicts death or transplantation in adults with a Fontan circulation.
    Am Heart J. 2017;189:184-192.
    PubMed     Text format     Abstract available


    June 2017
  21. TER MAATEN JM, Maggioni AP, Latini R, Masson S, et al
    Clinical and prognostic value of spot urinary creatinine in chronic heart failure-An analysis from GISSI-HF.
    Am Heart J. 2017;188:189-195.
    PubMed     Text format     Abstract available


  22. BRISCO-BACIK MA
    Prognostication on the spot! The evolving importance of urinary creatinine in heart failure.
    Am Heart J. 2017;188:186-188.
    PubMed     Text format    


  23. GOLDBERG SL, Meredith I, Marwick T, Haluska BA, et al
    A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure-Trial design of the REDUCE FMR study.
    Am Heart J. 2017;188:167-174.
    PubMed     Text format     Abstract available


  24. RASLAN IR, Brown P, Westerhout CM, Ezekowitz JA, et al
    Characterization of hemodynamically stable acute heart failure patients requiring a critical care unit admission: Derivation, validation, and refinement of a risk score.
    Am Heart J. 2017;188:127-135.
    PubMed     Text format     Abstract available


  25. VUKADINOVIC D, Lavall D, Vukadinovic AN, Pitt B, et al
    True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: A meta-analysis.
    Am Heart J. 2017;188:99-108.
    PubMed     Text format     Abstract available


  26. MOGENSEN UM, Kober L, Kristensen SL, Jhund PS, et al
    The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF.
    Am Heart J. 2017;188:35-41.
    PubMed     Text format     Abstract available


  27. JOHANSEN ND, Biering-Sorensen T, Jensen JS, Mogelvang R, et al
    Diastolic dysfunction revisited: A new, feasible, and unambiguous echocardiographic classification predicts major cardiovascular events.
    Am Heart J. 2017;188:136-146.
    PubMed     Text format     Abstract available


    May 2017
  28. PANG PS, Teerlink JR, Boer-Martins L, Gimpelewicz C, et al
    Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial.
    Am Heart J. 2017;187:62-69.
    PubMed     Text format     Abstract available


    April 2017
  29. BAEZA-TRINIDAD R, Mosquera-Lozano JD
    Bendopnea: The next prognostic marker of advanced heart failure?
    Am Heart J. 2017;186:e1.
    PubMed     Text format    


  30. ECHOUFFO-TCHEUGUI JB, Bishu KG, Fonarow GC, Egede LE, et al
    Trends in health care expenditure among US adults with heart failure: The Medical Expenditure Panel Survey 2002-2011.
    Am Heart J. 2017;186:63-72.
    PubMed     Text format     Abstract available


  31. AMBROSY AP, Cerbin LP, DeVore AD, Greene SJ, et al
    Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial.
    Am Heart J. 2017;186:130-138.
    PubMed     Text format     Abstract available


  32. FLINT K
    Cardiac rehabilitation in heart failure with reduced ejection fraction: A "take it or leave it" intervention.
    Am Heart J. 2017;186:127-129.
    PubMed     Text format    


    March 2017
  33. KUPSKY DF, Ahmed AM, Sakr S, Qureshi WT, et al
    Cardiorespiratory fitness and incident heart failure: The Henry Ford ExercIse Testing (FIT) Project.
    Am Heart J. 2017;185:35-42.
    PubMed     Text format     Abstract available


  34. REEVES GR, Whellan DJ, Duncan P, O'Connor CM, et al
    Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: Design and rationale.
    Am Heart J. 2017;185:130-139.
    PubMed     Text format     Abstract available


  35. CHAMBERLAIN AM, Alonso A, Gersh BJ, Manemann SM, et al
    Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.
    Am Heart J. 2017;185:74-84.
    PubMed     Text format     Abstract available


  36. ROBINSON VM, Bharucha DB, Mahaffey KW, Dorian P, et al
    Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial.
    Am Heart J. 2017;185:43-51.
    PubMed     Text format     Abstract available


  37. BARRIOS D, Morillo R, Lobo JL, Nieto R, et al
    Assessment of right ventricular function in acute pulmonary embolism.
    Am Heart J. 2017;185:123-129.
    PubMed     Text format     Abstract available


  38. HORNE BD, Budge D, Masica AL, Savitz LA, et al
    Early inpatient calculation of laboratory-based 30-day readmission risk scores empowers clinical risk modification during index hospitalization.
    Am Heart J. 2017;185:101-109.
    PubMed     Text format     Abstract available


  39. RICCI F, Mele D, Bianco F, Bucciarelli V, et al
    Right heart-pulmonary circulation unit and cardiac resynchronization therapy.
    Am Heart J. 2017;185:1-16.
    PubMed     Text format     Abstract available


    February 2017
  40. KHAN H, Jaffar N, Rauramaa R, Kurl S, et al
    Cardiorespiratory fitness and nonfatalcardiovascular events: A population-based follow-up study.
    Am Heart J. 2017;184:55-61.
    PubMed     Text format     Abstract available


    January 2017
  41. VERMA AK, Schulte PJ, Bittner V, Keteyian SJ, et al
    Socioeconomic and partner status in chronic heart failure: Relationship to exercise capacity, quality of life, and clinical outcomes.
    Am Heart J. 2017;183:54-61.
    PubMed     Text format     Abstract available


  42. COX ZL, Lewis CM, Lai P, Lenihan DJ, et al
    Validation of an automated electronic algorithm and "dashboard" to identify and characterize decompensated heart failure admissions across a medical center.
    Am Heart J. 2017;183:40-48.
    PubMed     Text format     Abstract available


  43. NAGARAJAN V, Hernandez AV, Cauthen CA, Starling RC, et al
    Usefulness of cell-mediated immune function in risk stratification for patients with advanced heart failure.
    Am Heart J. 2017;183:35-39.
    PubMed     Text format     Abstract available


  44. STEINHAUS DA, Mostofsky E, Levitan EB, Dorans KS, et al
    Chocolate intake and incidence of heart failure: Findings from the Cohort of Swedish Men.
    Am Heart J. 2017;183:18-23.
    PubMed     Text format     Abstract available


  45. THIBODEAU JT, Jenny BE, Maduka JO, Divanji PH, et al
    Bendopnea and risk of adverse clinical outcomes in ambulatory patients with systolic heart failure.
    Am Heart J. 2017;183:102-107.
    PubMed     Text format     Abstract available


    December 2016
  46. ECHOUFFO-TCHEUGUI JB, Xu H, DeVore AD, Schulte PJ, et al
    Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry.
    Am Heart J. 2016;182:9-20.
    PubMed     Text format     Abstract available


  47. SPITZER E, Van Mieghem NM, Pibarot P, Hahn RT, et al
    Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial.
    Am Heart J. 2016;182:80-88.
    PubMed     Text format     Abstract available


    November 2016
  48. LEE DS, Lee JS, Schull MJ, Grimshaw JM, et al
    Design and rationale for the Acute Congestive Heart Failure Urgent Care Evaluation: The ACUTE Study.
    Am Heart J. 2016;181:60-65.
    PubMed     Text format     Abstract available


  49. PROIETTI M, Laroche C, Drozd M, Vijgen J, et al
    Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Am Heart J. 2016;181:83-91.
    PubMed     Text format     Abstract available


    September 2016
  50. THUNE JJ, Pehrson S, Nielsen JC, Haarbo J, et al
    Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH).
    Am Heart J. 2016;179:136-41.
    PubMed     Text format     Abstract available


  51. GILOTRA NA, Bennett MK, Shpigel A, Ahmed HM, et al
    Outcomes and predictors of recovery in acute-onset cardiomyopathy: A single-center experience of patients undergoing endomyocardial biopsy for new heart failure.
    Am Heart J. 2016;179:116-26.
    PubMed     Text format     Abstract available


  52. SHREIBATI JB, Sheng S, Fonarow GC, DeVore AD, et al
    Heart failure medications prescribed at discharge for patients with left ventricular assist devices.
    Am Heart J. 2016;179:99-106.
    PubMed     Text format     Abstract available


  53. YAZDAN-ASHOORI P, Lee SF, Ibrahim Q, Van Spall HG, et al
    Utility of the LACE index at the bedside in predicting 30-day readmission or death in patients hospitalized with heart failure.
    Am Heart J. 2016;179:51-8.
    PubMed     Text format     Abstract available


  54. MCNEELY C, Markwell S, Vassileva CM
    Readmission after inpatient percutaneous coronary intervention in the Medicare population from 2000 to 2012.
    Am Heart J. 2016;179:195-203.
    PubMed     Text format     Abstract available


  55. BUCK J, Kaboli P, Gage BF, Cram P, et al
    Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System.
    Am Heart J. 2016;179:186-91.
    PubMed     Text format     Abstract available


  56. MARSO SP, McGuire DK, Zinman B, Poulter NR, et al
    Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1.
    Am Heart J. 2016;179:175-83.
    PubMed     Text format     Abstract available


  57. SHAH R, Hellkamp A, Lokhnygina Y, Becker RC, et al
    Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial.
    Am Heart J. 2016;179:77-86.
    PubMed     Text format     Abstract available


    August 2016
  58. DEVORE AD, Greiner MA, Sharma PP, Qualls LG, et al
    Development and validation of a risk model for in-hospital worsening heart failure from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Am Heart J. 2016;178:198-205.
    PubMed     Text format     Abstract available


  59. ALLEN LA, McIlvennan CK
    Predicting in-hospital worsening heart failure at time of admission, but do we really need another heart failure risk model?
    Am Heart J. 2016;178:188-9.
    PubMed     Text format    


  60. MALEBRANCHE R, Tabou Moyo C, Morisset PH, Raphael NA, et al
    Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti.
    Am Heart J. 2016;178:151-60.
    PubMed     Text format     Abstract available


  61. PAINE NJ, Hinderliter AL, Blumenthal JA, Adams KF Jr, et al
    Reactive hyperemia is associated with adverse clinical outcomes in heart failure.
    Am Heart J. 2016;178:108-14.
    PubMed     Text format     Abstract available


  62. FROHLICH H, Nelges C, Tager T, Schwenger V, et al
    Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
    Am Heart J. 2016;178:28-36.
    PubMed     Text format     Abstract available


    July 2016
  63. PEGUERO JG, Lo Presti S, Issa O, Podesta C, et al
    Simplified prediction of postoperative cardiac surgery outcomes with a novel score: R2CHADS2.
    Am Heart J. 2016;177:153-9.
    PubMed     Text format     Abstract available


  64. KIM EJ, Yin X, Fontes JD, Magnani JW, et al
    Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study).
    Am Heart J. 2016;177:138-44.
    PubMed     Text format     Abstract available


  65. BAKKESTROM R, Larsen LA, Moller JE, Videbaek L, et al
    Mitral valve regurgitation in twins: Concordance and survival.
    Am Heart J. 2016;177:51-7.
    PubMed     Text format     Abstract available


    May 2016
  66. PAPADIMITRIOU L, Smith-Jones PM, Sarwar CM, Marti CN, et al
    Utility of positron emission tomography for drug development for heart failure.
    Am Heart J. 2016;175:142-52.
    PubMed     Text format     Abstract available


    April 2016
  67. SHAFIQ A, Brawner CA, Aldred HA, Lewis B, et al
    Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal CardioPulmonary EXercise Testing (FIT-CPX) project.
    Am Heart J. 2016;174:167-72.
    PubMed     Text format     Abstract available


  68. GUAZZI M
    Cardiopulmonary exercise testing in heart failure preserved ejection fraction: Time to expand the paradigm in the prognostic algorithm.
    Am Heart J. 2016;174:164-6.
    PubMed     Text format    


  69. AXON RN, Gebregziabher M, Everett CJ, Heidenreich P, et al
    Dual health care system use is associated with higher rates of hospitalization and hospital readmission among veterans with heart failure.
    Am Heart J. 2016;174:157-63.
    PubMed     Text format     Abstract available


  70. DESAI NR
    Toward evidence-based health care delivery reform.
    Am Heart J. 2016;174:154-6.
    PubMed     Text format    


    March 2016
  71. DEVORE AD, Mi X, Mentz RJ, Fonarow GC, et al
    Discharge heart rate and beta-blocker dose in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF registry.
    Am Heart J. 2016;173:172-8.
    PubMed     Text format     Abstract available


  72. COLE RT
    Making a case for ivabradine: Should we SHIFT our focus to OPTIMIZE outcomes?
    Am Heart J. 2016;173:170-1.
    PubMed     Text format    


    February 2016
  73. ABOUEZZEDDINE OF, Lala A, Khazanie PP, Shah R, et al
    Evaluation of a provocative dyspnea severity score in acute heart failure.
    Am Heart J. 2016;172:34-41.
    PubMed     Text format     Abstract available


    January 2016
  74. SHIRAISHI Y, Kohsaka S, Abe T, Mizuno A, et al
    Validation of the Get With The Guideline-Heart Failure risk score in Japanese patients and the potential improvement of its discrimination ability by the inclusion of B-type natriuretic peptide level.
    Am Heart J. 2016;171:33-9.
    PubMed     Text format     Abstract available


    December 2015
  75. COOPER LB, Hammill BG, Sharma PP, DeVore AD, et al
    Differences in health care use and outcomes by the timing of in-hospital worsening heart failure.
    Am Heart J. 2015;170:1124-32.
    PubMed     Text format     Abstract available


  76. VAKIL KP, Roukoz H, Tung R, Levy WC, et al
    Mortality prediction using a modified Seattle Heart Failure Model may improve patient selection for ventricular tachycardia ablation.
    Am Heart J. 2015;170:1099-104.
    PubMed     Text format     Abstract available


    November 2015
  77. FISCHER C, Steyerberg EW, Fonarow GC, Ganiats TG, et al
    A systematic review and meta-analysis on the association between quality of hospital care and readmission rates in patients with heart failure.
    Am Heart J. 2015;170:1005-1017.
    PubMed     Text format     Abstract available


  78. GILSTRAP LG, Joynt KE
    Both processes and readmissions matter for heart failure: How can we align them?
    Am Heart J. 2015;170:968-70.
    PubMed     Text format    


  79. LAZO M, Halushka MK, Shen L, Maruthur N, et al
    Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study.
    Am Heart J. 2015;170:961-7.
    PubMed     Text format     Abstract available


  80. REED SD, Neilson MP, Gardner M, Li Y, et al
    Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure.
    Am Heart J. 2015;170:951-60.
    PubMed     Text format     Abstract available


  81. SNIPELISKY D, Stulak JM, Schettle SD, Sharma S, et al
    Psychosocial characteristics and outcomes in patients with left ventricular assist device implanted as destination therapy.
    Am Heart J. 2015;170:887-94.
    PubMed     Text format     Abstract available


    October 2015
  82. DOKAINISH H, Teo K, Zhu J, Roy A, et al
    Heart failure in low- and middle-income countries: Background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF).
    Am Heart J. 2015;170:627-634.
    PubMed     Text format     Abstract available


    September 2015
  83. CHAUHAN V, Dev S, Pham M, Lin S, et al
    Facility variation and predictors of serum potassium monitoring after initiation of a mineralocorticoid receptor antagonist in patients with heart failure.
    Am Heart J. 2015;170:543-9.
    PubMed     Text format     Abstract available


  84. SALAH K, Pinto YM, Eurlings LW, Metra M, et al
    Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis.
    Am Heart J. 2015;170:531-542.
    PubMed     Text format     Abstract available


  85. LUM HD, Jones J, Lahoff D, Allen LA, et al
    Unique challenges of hospice for patients with heart failure: A qualitative study of hospice clinicians.
    Am Heart J. 2015;170:524-530.
    PubMed     Text format     Abstract available


  86. COSTANZO MR, Negoianu D, Fonarow GC, Jaski BE, et al
    Rationale and design of the Aquapheresis Versus Intravenous Diuretics and Hospitalization for Heart Failure (AVOID-HF) trial.
    Am Heart J. 2015;170:471-82.
    PubMed     Text format     Abstract available


    August 2015
  87. TER MAATEN JM, Dunning AM, Valente MA, Damman K, et al
    Diuretic response in acute heart failure-an analysis from ASCEND-HF.
    Am Heart J. 2015;170:313-321.
    PubMed     Text format     Abstract available


  88. CORRALES-MEDINA VF, Taljaard M, Yende S, Kronmal R, et al
    Intermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults.
    Am Heart J. 2015;170:306-312.
    PubMed     Text format     Abstract available


  89. KELLY JP, Mentz RJ, Hasselblad V, Ezekowitz JA, et al
    Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF).
    Am Heart J. 2015;170:298-305.
    PubMed     Text format     Abstract available


  90. KHAZANIE P, Heizer GM, Hasselblad V, Armstrong PW, et al
    Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models.
    Am Heart J. 2015;170:290-297.
    PubMed     Text format     Abstract available


  91. RUSSO AM, Daugherty SL, Masoudi FA, Wang Y, et al
    Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR).
    Am Heart J. 2015;170:330-8.
    PubMed     Text format     Abstract available


  92. HEIDENREICH PA, Tsai V, Curtis J, Wang Y, et al
    A validated risk model for 1-year mortality after primary prevention implantable cardioverter defibrillator placement.
    Am Heart J. 2015;170:281-289.
    PubMed     Text format     Abstract available


  93. ZEITLER EP, Al-Khatib SM
    Primary prevention implantable cardioverter defibrillators in women: More questions than answers.
    Am Heart J. 2015;170:197-9.
    PubMed     Text format    


    July 2015
  94. CAPODANNO D, Adamo M, Barbanti M, Giannini C, et al
    Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair.
    Am Heart J. 2015;170:187-95.
    PubMed     Text format     Abstract available


  95. CHRISTODOULIDIS G, Yu J, Kini A, Dangas GD, et al
    Gender-specific outcomes after balloon aortic valvuloplasty: Inhospital and long-term outcomes.
    Am Heart J. 2015;170:180-6.
    PubMed     Text format     Abstract available


  96. DAMLUJI AA, Al-Damluji MS, Marzouka GR, Coffey JO, et al
    New-onset versus prior history of atrial fibrillation: Outcomes from the AFFIRM trial.
    Am Heart J. 2015;170:156-163.
    PubMed     Text format     Abstract available


  97. POKORNEY SD, Simon DN, Thomas L, Fonarow GC, et al
    Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.
    Am Heart J. 2015;170:141-148.
    PubMed     Text format     Abstract available


  98. OKRAINEC K, Bell CM, Hollands S, Booth GL, et al
    Risk of cardiovascular events and mortality among a population-based cohort of immigrants and long-term residents with diabetes: Are all immigrants healthier and if so, for how long?
    Am Heart J. 2015;170:123-32.
    PubMed     Text format     Abstract available


    June 2015
  99. KIM KH, Kim HK, Hwang IC, Cho HJ, et al
    PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A 12-week, randomized, double-blind, placebo-controlled trial.
    Am Heart J. 2015;169:813-822.
    PubMed     Text format     Abstract available


  100. GRODIN JL, Drazner MH, Dupont M, Mullens W, et al
    A disproportionate elevation in right ventricular filling pressure, in relation to left ventricular filling pressure, is associated with renal impairment and increased mortality in advanced decompensated heart failure.
    Am Heart J. 2015;169:806-12.
    PubMed     Text format     Abstract available


    May 2015
  101. OH J, Kang SM, Song MK, Hong N, et al
    Clinical benefit of spironolactone in patients with acute decompensated heart failure and severe renal dysfunction: Data from the Korean Heart Failure Registry.
    Am Heart J. 2015;169:713-720.
    PubMed     Text format     Abstract available


  102. SCHROTEN NF, Damman K, Hemmelder MH, Voors AA, et al
    Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Hea
    Am Heart J. 2015;169:693-701.
    PubMed     Text format     Abstract available


  103. RUSSO C, Jin Z, Homma S, Rundek T, et al
    Race-ethnic differences in subclinical left ventricular systolic dysfunction by global longitudinal strain: A community-based cohort study.
    Am Heart J. 2015;169:721-6.
    PubMed     Text format     Abstract available


  104. HAHN JY, Yu CW, Park HS, Song YB, et al
    Long-term effects of ischemic postconditioning on clinical outcomes: 1-year follow-up of the POST randomized trial.
    Am Heart J. 2015;169:639-46.
    PubMed     Text format     Abstract available


  105. HOFSTEN DE, Kelbaek H, Helqvist S, Klovgaard L, et al
    The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: Ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus treat
    Am Heart J. 2015;169:613-21.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: